Hepatitis C treatments don't seem to work as well in African Americans
Hepatitis C treatments don't seem to work as well in African Americans as in other groups...for hepatitis C virus (HCV) genotype 1.
Peginterferon alfa-2b (PEG-Intron) and ribavirin (Rebetol) are effective for HCV genotype 1 in 52% of whites...but only in 19% of African Americans.
Researchers used to think the difference in effectiveness was due to the treatment-resistant HCV genotype 1 that's more common in African Americans. But now research shows that the poor response is not explained by HCV genotype.